Quantedge Capital Pte Ltd Buys 62,400 Shares of BlackRock Health Sciences Term Trust $BMEZ

Quantedge Capital Pte Ltd increased its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report) by 85.0% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 135,854 shares of the company’s stock after acquiring an additional 62,400 shares during the period. BlackRock Health Sciences Term Trust comprises approximately 1.1% of Quantedge Capital Pte Ltd’s investment portfolio, making the stock its 21st largest holding. Quantedge Capital Pte Ltd’s holdings in BlackRock Health Sciences Term Trust were worth $1,951,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the stock. PNC Financial Services Group Inc. acquired a new position in shares of BlackRock Health Sciences Term Trust during the 1st quarter worth approximately $35,000. SouthState Bank Corp acquired a new stake in shares of BlackRock Health Sciences Term Trust in the 1st quarter valued at approximately $29,000. Calamos Advisors LLC bought a new position in shares of BlackRock Health Sciences Term Trust in the first quarter valued at $740,000. NWF Advisory Services Inc. grew its stake in shares of BlackRock Health Sciences Term Trust by 16.7% in the first quarter. NWF Advisory Services Inc. now owns 40,469 shares of the company’s stock valued at $581,000 after buying an additional 5,784 shares in the last quarter. Finally, Fifth Third Bancorp acquired a new position in BlackRock Health Sciences Term Trust during the first quarter worth $142,000.

BlackRock Health Sciences Term Trust Stock Up 1.1%

NYSE BMEZ opened at $15.30 on Wednesday. The firm’s fifty day moving average price is $14.75 and its two-hundred day moving average price is $14.72. BlackRock Health Sciences Term Trust has a 1 year low of $13.67 and a 1 year high of $15.80.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be paid a dividend of $0.11 per share. The ex-dividend date is Tuesday, September 15th. This represents a c) annualized dividend and a dividend yield of 8.6%.

BlackRock Health Sciences Term Trust Company Profile

(Free Report)

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.

Read More

Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report).

Institutional Ownership by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.